梅花生物(600873.SH):2017年第一期員工持股計劃展期
格隆匯12月11日丨梅花生物(600873.SH)公佈,2019年12月11日,公司第八屆董事會第三十六次會議審議通過了《關於2017年第一期員工持股計劃展期的議案》。
根據公司員工持股計劃的相關規定,2017年第一期員工持股計劃存續期為自股東大會審議通過之日起36個月,員工持股計劃存續期將於2020年1月15日屆滿。截止本公告出具日,公司員工持股計劃專户中,股份餘額為2884.5928萬股。
根據《梅花生物科技集團股份有限公司2017年第一期員工持股計劃》規定,員工持股計劃的存續期經員工持股計劃持有人會議通過並提交公司董事會審議通過後,可相應延長。鑑於員工持股計劃存續期將於2020年1月15日屆滿,基於對公司未來持續穩定發展的信心及公司股票價值的判斷,同時為了維護公司員工持股計劃持有人的利益,經員工持股計劃持有人會議審議,擬將2017年第一期員工持股計劃存續期延長24個月至2022年1月15日止。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.